Down syndrome – also known as trisomy 21 – is a serious genetic disorder, with four pregnancies out of five not reaching term naturally if the fetus is affected. However, 20% of conceptuses with Down syndrome are born live, grow up and can reach the age of 65.
How is this possible?
Researchers from the Universities of Geneva (UNIGE) and Lausanne (UNIL) hypothesised that individuals born with Down syndrome possess a high quality genome that has the ability to compensate for the effects of the third chromosome 21.
“The genome consists of all the genetic material that makes up an individual. It’s the genome that determines what becomes of a person, and makes him or her grow up and grow old, with or without disease. Some genomes are of better quality than others, and can also be less prone to illnesses such as cancer,”
explains Stylianos Antonarakis, the honorary professor in UNIGE’s Faculty of Medicine who led the research.
Gene Variation, Regulation And Expression
Basing their work on the hypothesis of a the quality of the genome, the geneticists tested the gene variation, regulation and expression of 380 individuals with Down syndrome and compared them to people without the genetic disorder.
The first test consisted of observing the presence of rare variants, i.e. potentially harmful genetic mutations, in people with Down. It is known that the a chromosome can have different rare variants in its two copies.
In a person with Down, however, the rare mutations that are identical for all three copies of chromosome 21 and limited in number, thereby reducing the total of potentially deleterious variants.
In a next step, the geneticists have studied the regulation of genes on chromosome 21. Each gene has switches that regulate its expression either positively or negatively.
Since people with Down have three chromosomes 21, most of these genes are overexpressed.
“But we discovered that people with Down syndrome have more regulators that diminish the expression of the 21 genes, making it possible to compensate for the surplus induced by the third copy,”
says Konstantin Popadin, a researcher at UNIL’s Center for Integrative Genomics.
Finally, the researchers focused on the variation gene expression for the chromosomes of the entire genome. Each gene expression on a scale from 0 to 100 forms part of a global spread curve, with the median – 50 – considered the ideal expression.
“For a normal genome, the expressions oscillate between 30 and 70, while for a person with Down syndrome, the curve is narrower around the peak that is very close to 50 for genes on all the chromosomes,” continues professor Antonarakis. “In other words, this means that the genome of someone with Down leans towards the average – optimal functioning.”
Indeed, the smaller the gene expression variations are, the better the genome.
The geneticists were thus able to test the three functions of genomes of people suffering from Down syndrome.
“The research has shown that for a child with Down to survive pregnancy and then grow, his or her genome must be of a higher quality so that it can compensate for the disabilities caused by the extra copy of chromosome 21,”
concludes Popadin. These conclusions may also apply to other serious genetic disorders where pregnancies reach full term.
Konstantin Popadin, Stephan Peischl, Marco Garieri, M. Reza Sailani, Audrey Letourneau, Federico Santoni, Samuel W. Lukowski, Georgii A. Bazykin, Sergey Nikolaev, Diogo Meyer, Laurent Excoffier, Alexandre Reymond, and Stylianos E. Antonarakis
Slightly deleterious genomic variants and transcriptome perturbations in Down syndrome embryonic selection
Genome Res. January 2018 28: 1-10; doi:10.1101/gr.228411.117
Image: Down syndrome human karyotype 47,XY,+21 by Wessex Reg. Genetics Centre. Credit: Wessex Reg. Genetics Centre. CC BY